Keep Me Logged In
Regeneron Pharmaceuticals president & CEO Dr. Leonard Schleifer provides insight into the early stages of its macular degeneration drug Eylea, its strong partnership with Sanofi and other drugs in its pipeline to treat allergic diseases.
Got a confidential news tip? We want to hear from you.
Sign up for free newsletters and get more CNBC delivered to your inbox
© 2018 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by